Blackstone Closes Cardinal PTS Acquisition

Cardinal Health (NYSE: CAH) has completed the sale of its pharmaceutical technologies and services (PTS) business to The Blackstone Group for approximately $3.3 billion. PTS develops, manufactures and packages medication and other products for pharma and biotech firms, and employs approximately 10,000 people at more than 30 global facilities. It generates approximately $1.8 billion in annual revenue.